1 Study Coverage
1.1 GP Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global GP Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global GP Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global GP Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global GP Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global GP Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global GP Vaccination Sales by Region
2.4.1 Global GP Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales GP Vaccination by Region (2023-2028)
2.5 Global GP Vaccination Revenue by Region
2.5.1 Global GP Vaccination Revenue by Region (2017-2022)
2.5.2 Global GP Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global GP Vaccination Sales by Manufacturers
3.1.1 Global Top GP Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global GP Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GP Vaccination in 2021
3.2 Global GP Vaccination Revenue by Manufacturers
3.2.1 Global GP Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global GP Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by GP Vaccination Revenue in 2021
3.3 Global GP Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global GP Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GP Vaccination Sales by Type
4.1.1 Global GP Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global GP Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global GP Vaccination Sales Market Share by Type (2017-2028)
4.2 Global GP Vaccination Revenue by Type
4.2.1 Global GP Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global GP Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global GP Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global GP Vaccination Price by Type
4.3.1 Global GP Vaccination Price by Type (2017-2022)
4.3.2 Global GP Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global GP Vaccination Sales by Application
5.1.1 Global GP Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global GP Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global GP Vaccination Sales Market Share by Application (2017-2028)
5.2 Global GP Vaccination Revenue by Application
5.2.1 Global GP Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global GP Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global GP Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global GP Vaccination Price by Application
5.3.1 Global GP Vaccination Price by Application (2017-2022)
5.3.2 Global GP Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America GP Vaccination Market Size by Type
6.1.1 North America GP Vaccination Sales by Type (2017-2028)
6.1.2 North America GP Vaccination Revenue by Type (2017-2028)
6.2 North America GP Vaccination Market Size by Application
6.2.1 North America GP Vaccination Sales by Application (2017-2028)
6.2.2 North America GP Vaccination Revenue by Application (2017-2028)
6.3 North America GP Vaccination Market Size by Country
6.3.1 North America GP Vaccination Sales by Country (2017-2028)
6.3.2 North America GP Vaccination Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe GP Vaccination Market Size by Type
7.1.1 Europe GP Vaccination Sales by Type (2017-2028)
7.1.2 Europe GP Vaccination Revenue by Type (2017-2028)
7.2 Europe GP Vaccination Market Size by Application
7.2.1 Europe GP Vaccination Sales by Application (2017-2028)
7.2.2 Europe GP Vaccination Revenue by Application (2017-2028)
7.3 Europe GP Vaccination Market Size by Country
7.3.1 Europe GP Vaccination Sales by Country (2017-2028)
7.3.2 Europe GP Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific GP Vaccination Market Size by Type
8.1.1 Asia Pacific GP Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific GP Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific GP Vaccination Market Size by Application
8.2.1 Asia Pacific GP Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific GP Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific GP Vaccination Market Size by Region
8.3.1 Asia Pacific GP Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific GP Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America GP Vaccination Market Size by Type
9.1.1 Latin America GP Vaccination Sales by Type (2017-2028)
9.1.2 Latin America GP Vaccination Revenue by Type (2017-2028)
9.2 Latin America GP Vaccination Market Size by Application
9.2.1 Latin America GP Vaccination Sales by Application (2017-2028)
9.2.2 Latin America GP Vaccination Revenue by Application (2017-2028)
9.3 Latin America GP Vaccination Market Size by Country
9.3.1 Latin America GP Vaccination Sales by Country (2017-2028)
9.3.2 Latin America GP Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa GP Vaccination Market Size by Type
10.1.1 Middle East and Africa GP Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa GP Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa GP Vaccination Market Size by Application
10.2.1 Middle East and Africa GP Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa GP Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa GP Vaccination Market Size by Country
10.3.1 Middle East and Africa GP Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa GP Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Corporation Information
11.1.2 Moderna Overview
11.1.3 Moderna GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Recent Developments
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Corporation Information
11.2.2 CanSino Biologicals Overview
11.2.3 CanSino Biologicals GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CanSino Biologicals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CanSino Biologicals Recent Developments
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Corporation Information
11.3.2 Inovio Pharmaceuticals Overview
11.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Inovio Pharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inovio Pharmaceuticals Recent Developments
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
11.4.2 Shenzhen Geno-Immune Medical Institute Overview
11.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Corporation Information
11.5.2 GlaxoSmithKine Overview
11.5.3 GlaxoSmithKine GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKine GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKine Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Corporation Information
11.7.2 Johnson＆Johnson Overview
11.7.3 Johnson＆Johnson GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson＆Johnson GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson＆Johnson Recent Developments
11.8 Heat Biologics
11.8.1 Heat Biologics Corporation Information
11.8.2 Heat Biologics Overview
11.8.3 Heat Biologics GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Heat Biologics GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Heat Biologics Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Takis Biotech
11.10.1 Takis Biotech Corporation Information
11.10.2 Takis Biotech Overview
11.10.3 Takis Biotech GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takis Biotech GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takis Biotech Recent Developments
11.11 Zydus Cadila
11.11.1 Zydus Cadila Corporation Information
11.11.2 Zydus Cadila Overview
11.11.3 Zydus Cadila GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zydus Cadila GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zydus Cadila Recent Developments
11.12 Codagenix
11.12.1 Codagenix Corporation Information
11.12.2 Codagenix Overview
11.12.3 Codagenix GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Codagenix GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Codagenix Recent Developments
11.13 GeoVax
11.13.1 GeoVax Corporation Information
11.13.2 GeoVax Overview
11.13.3 GeoVax GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 GeoVax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 GeoVax Recent Developments
11.14 Bravovax
11.14.1 Bravovax Corporation Information
11.14.2 Bravovax Overview
11.14.3 Bravovax GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Bravovax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bravovax Recent Developments
11.15 Altimmune
11.15.1 Altimmune Corporation Information
11.15.2 Altimmune Overview
11.15.3 Altimmune GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Altimmune GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Altimmune Recent Developments
11.16 Vaxart
11.16.1 Vaxart Corporation Information
11.16.2 Vaxart Overview
11.16.3 Vaxart GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Vaxart GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Vaxart Recent Developments
11.17 Clover Biopharmaceuticals
11.17.1 Clover Biopharmaceuticals Corporation Information
11.17.2 Clover Biopharmaceuticals Overview
11.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Clover Biopharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Clover Biopharmaceuticals Recent Developments
11.18 ImmunoPrecise
11.18.1 ImmunoPrecise Corporation Information
11.18.2 ImmunoPrecise Overview
11.18.3 ImmunoPrecise GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 ImmunoPrecise GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ImmunoPrecise Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GP Vaccination Industry Chain Analysis
12.2 GP Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GP Vaccination Production Mode & Process
12.4 GP Vaccination Sales and Marketing
12.4.1 GP Vaccination Sales Channels
12.4.2 GP Vaccination Distributors
12.5 GP Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 GP Vaccination Industry Trends
13.2 GP Vaccination Market Drivers
13.3 GP Vaccination Market Challenges
13.4 GP Vaccination Market Restraints
14 Key Findings in The Global GP Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
